Translational Development Acquisition Corp. - Ordinary Shares (NQ:TDAC)
Price and Volume
Detailed Quote| Volume | 304,144 |
| Open | 10.73 |
| Bid (Size) | 10.75 (100) |
| Ask (Size) | 10.76 (1,000) |
| Prev. Close | 10.73 |
| Today's Range | 10.73 - 10.80 |
| 52wk Range | 10.19 - 10.74 |
| Shares Outstanding | 5,139,652 |
| Dividend Yield | N/A |
Top News
More News
Performance
Frequently Asked Questions
Is Translational Development Acquisition Corp. - Ordinary Shares publicly traded?
Yes, Translational Development Acquisition Corp. - Ordinary Shares is publicly traded.
What exchange does Translational Development Acquisition Corp. - Ordinary Shares trade on?
Translational Development Acquisition Corp. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Translational Development Acquisition Corp. - Ordinary Shares?
The ticker symbol for Translational Development Acquisition Corp. - Ordinary Shares is TDAC on the Nasdaq Stock Market
What is the current price of Translational Development Acquisition Corp. - Ordinary Shares?
The current price of Translational Development Acquisition Corp. - Ordinary Shares is 10.76
When was Translational Development Acquisition Corp. - Ordinary Shares last traded?
The last trade of Translational Development Acquisition Corp. - Ordinary Shares was at 05/28/26 04:00 PM ET
What is the market capitalization of Translational Development Acquisition Corp. - Ordinary Shares?
The market capitalization of Translational Development Acquisition Corp. - Ordinary Shares is 55.30M
How many shares of Translational Development Acquisition Corp. - Ordinary Shares are outstanding?
Translational Development Acquisition Corp. - Ordinary Shares has 55M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube